OncoMed Pharmaceuticals, Inc.
     
 
 

Board of Directors

Perry Karsen
Executive Chairman of the Board, OncoMed Pharmaceuticals. Former Chief Executive Officer of Celgene Cellular Therapeutics
John Lewicki, Ph.D.
President and Chief Executive Officer, OncoMed Pharmaceuticals
Jack W. Lasersohn J.D.
General Partner, The Vertical Group
Deepa R. Pakianathan Ph.D.
General Partner, Delphi Ventures
Michael Wyzga
Former President and Chief Executive Officer, Radius Health, Inc.

Stock transaction information provided by EDGAR Online. OncoMed Pharmaceuticals makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Stock Quote (NASDAQ: OMED)
Price:
2.32
Change:
- 0.08
Day High:
2.45
Day Low:
2.30
Volume:
233,075
4:00 PM ET on Sep 21, 2018
Delayed at least 20 minutes.
Provided by eSignal.
Search Investor Relations